Shares of Minerva Neurosciences Inc (NASDAQ:NERV) have received an average recommendation of “Buy” from the seven research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokerages that […]
Minerva Neurosciences (NASDAQ:NERV) and Beigene (NASDAQ:BGNE) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Analyst Recommendations This is a breakdown of recent recommendations for Minerva Neurosciences and Beigene, as reported by […]
Minerva Neurosciences (NASDAQ:NERV) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a report released on Tuesday, ValuEngine reports. A number of other analysts have also recently weighed in on NERV. JMP Securities cut their price target on Minerva Neurosciences from $20.00 to $18.00 and set a […]
Minerva Neurosciences Inc (NASDAQ:NERV) has earned an average recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average […]
Neanderthal (Homo neanderthalensis) fossils were first discovered in western Europe in the mid nineteenth century. That was just the first in a long line of surprises thrown up by our closest evolutionary cousins.
Analysts predict that Minerva Neurosciences Inc (NASDAQ:NERV) will report earnings of ($0.41) per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Minerva Neurosciences’ earnings, with the highest EPS estimate coming in at ($0.36) and the lowest estimate coming in at ($0.49). Minerva Neurosciences reported earnings of ($0.34) […]
With its promise to bring new insights into the diagnosis and treatment of conditions as varied as cancer, cardiovascular and neurodegenerative diseases, bioelectronic medicine is now in the spotlight. ...